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Abstract
Papillomaviruses (PVs) are believed to be highly epitheliotropic as they usually establish productive infections within
stratified epithelia. In vitro, various PVs appear to complete their entire life-cycle in different trophoblastic cell lines. In this
study, infection by and protein expression of bovine papillomavirus type 2 (BPV-2) in the uterine and chorionic epithelium
of the placenta has been described in four cows suffering from naturally occurring papillomavirus-associated urothelial
bladder tumors. E5 oncoprotein was detected both by Western blot analysis and immunohistochemically. It appears to be
complexed and perfectly co-localized with the activated platelet-derived growth factor ß receptor (PDGFßR) by laser
scanning confocal microscopy. The activated PDGFßR might be involved in organogenesis and neo-angiogenesis rather
than in cell transformation during pregnancy. The major capsid protein, L1, believed to be only expressed in productive
papillomavirus infection has been detected by Western blot analysis. Immunohistochemical investigations confirmed the
presence of L1 protein both in the cytoplasm and nuclei of cells of the uterine and chorionic epithelium. Trophoblastic cells
appear to be the major target for L1 protein expression. Finally, the early protein E2, required for viral DNA replication and
known to be expressed during a productive infection, has been detected by Western blot and immunohistochemically.
Electron microscopic investigations detected viral particles in nuclei of uterine and chorionic epithelium. This study shows
that both active and productive infections by BPV-2 in the placenta of pregnant cows can occur in vivo.
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Introduction
Bovine papillomavirus type 2 (BPV-2) infection is common in
cattle on pasture and grazing on bracken fern infested lands. This
often results in tumors of the urinary bladder [1,2]. Recent studies
revealed BPV-2 DNA sequences in ,50% of urinary bladder
samples from free-ranging apparently healthy cattle and in ,78%
of bovine neoplastic urinary bladder samples [1,3]. It is currently
presumed that BPV-2 acts synergistically with immunosuppressive,
mutagenic and carcinogenic chemicals of bracken fern in
molecular pathway(s) leading to bladder carcinogenesis [1]. In
more than 90% of cases, tumors of the urinary bladder cause a
severe clinical syndrome known as chronic enzootic hematuria
(CEH) [4].
Papillomaviruses (PVs) are believed to be highly epitheliotropic
as they usually establish productive infections within stratified
epithelia only [5,6]. BPV-1/-2 are closely related serotypes and are
the only ones known to infect both epithelial and mesenchymal
tissues [5,7]. Similar to other PVs, BPV-1/-2 replication and
virion production appear to be confined to the epithelial region of
the lesions [7]. However, new host cell types are emerging [8] and
the list of new PV tissue tropisms is still increasing [9,10,11,12].
Recently, a naturally occurring BPV-2 productive infection has
been shown to take place in peripheral blood mononuclear cells
(PBMCs) of cattle suffering from tumors of the urinary bladder
[10], which demonstrates that hematogenous spreading of the
virus by blood stream is an actual occurrence.
It has been reported that HPV could infect human placenta
[9,11]. However, studies evaluating the presence of PVs in
intrauterine tissues including placenta are controversial in so far as
data can be interpreted as evidence for an active infection or the
result of contamination events [13].
It has been shown that multiple types of human papillomavirus
(HPV) could infect and replicate in non-invasive trophoblast cell
lines (3A trophoblast cells) [14]. Furthermore, HPV infections of
the BeWo and HTR-8/SVneo cell lines have been reported
[9,15]. Both cell line systems share many phenotypic features with
the extravillous, invasive trophoblastic cells of the normal human
first-trimester placenta.
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33569The aim of the present report was to document that the
placenta of cows is an anatomical site of real, naturally occurring
BPV-2 infection and that BPV-2 completes its life cycle in the
uterine endometrial and chorionic epithelium. Therefore, this
study is the first to reveal that the placenta of pregnant cows
affected by BPV-2-induced urothelial bladder tumors is an
additional site of BPV-2 infection, where viral proteins are
expressed and virion assembly occurs.
Materials and Methods
Ethics Statement
In this study we did not perform any animal experiments. We
collected the samples directly from public slaughterhouses; the
animals were slaughtered following owner’s decisions and after a
mandatory clinical ante-mortem examination, as required by the
European Union legislation.
Immunoprecipitation of BPV-2 E5 oncoprotein in blood
samples
Our veterinarian colleagues collected peripheral blood samples
in tubes to perform serum investigation to eradicate brucellosis
and leukosis according to Italian legislation. Four of the animals
for which blood test were performed were suffering from chronic
enzootic hematuria for several years as clinically determined.
Blood samples of the hematuric cows were brought to the
laboratory during an ongoing study on papillomavirus biology
[10]. The peripheral blood mononuclear cell samples proved
positive for BPV-2 E5 oncoprotein [10].
Tissue Samples
The hematuric cows were slaughtered at public slaughterhouses
in southern Italy; they were found to be pregnant. Post-mortem
examination revealed the presence of severe neoplastic lesions
scattered on the bladder mucosa. Bladder and placenta tissue
specimens were sampled. To prevent possible cross-contamina-
tions, each sample was immediately divided into several parts that
were frozen in liquid nitrogen for subsequent molecular biological
analysis, or fixed in 10% buffered formalin for protein expression
assays.
Histopathology
Tissues fixed in 10% neutral buffered formalin were routinely
processed for paraffin embedding. Histologic diagnosis of bladder
tumors was assessed on 5-mm-thick hematoxylin-eosin (HE)-
stained sections following recently suggested morphological
criteria [2].
BPV-2 DNA Detection
DNA was extracted from placental samples from cows affected
with urothelial bladder tumors as well as from apparently healthy
cows using the DNeasy Tissue Kit (Qiagen) according to the
manufacturer’s protocol. All the samples were lysed using
proteinase K. Lysates were loaded onto DNeasy spin columns.
After two washings pure DNA was eluted in low salt buffer. For
the detection of BPV-2 DNA specific primers for the E5 region
were designed by Beacon Designer 2.0 software as reported
elsewhere [16]. The forward primer BPV-2NS (59-
TACTGTTTCTGCTGCTATTT-39) and the reverse primer
BPV-2NAS (59-ACAAATCAAATCCACATAATAGTA-39) am-
plified a fragment of 125 bp from 3943 to 4067 of complete
genome of BPV-2. To evaluate the adequacy of the DNA, a
control PCR for bovine b-actin sequence was performed using a
set of primers (forward, 59-GAGCGTGGCTACAGCTTCAC-39;
reverse, 59-CATTGCCGATGGTGATGA-39).
Aliquots 50–100 ng of purified DNA were amplified in 25 mlo f
reaction mixture containing 1.5 mM MgCl2 for b-actin primers
and 2 mM for BPV-2 primers, 200 mM each dNTP, 480 nM of
each primer and 2.5 U of AmpliTaq Gold DNA Polymerase
(Applied Biosystems, Monza, Italy). The reaction was carried out
in a thermocycler (Veriti, Applied Biosystems) with an initial
denaturation step of 2 min and 30 sec. Then, 35 cycles of
amplification were carried out with a denaturation step at 95uC for
30 sec, an annealing step at 60uC, 1 min, for b-actin or at 50uC,
30 sec, for BPV-2, and an extension step at 72uC for 1 min. A
final extension step at 72uC for 5 min was performed in each PCR
assay. Detection of the amplified products was carried out by
electrophoresis on ethidium bromide-stained agarose gel. In each
experiment, a blank sample consisting of reaction mixture without
DNA and a positive sample consisting of BPV-2 clone DNA (a
kind gift by Dr. A. Venuti) were included. Five ml of the amplified
products were subjected to a second run of PCR under the same
experimental conditions. Amplified products from the last PCR
were electrophoresed in a 2,5% agarose gel and visualized by
ethidium bromide stain. The quality of DNA was tested with
primers for bovine b-actin gene.
BPV-2 E5 Immunoprecipitation
Tissue samples from placenta were lysed in ice-cold buffer
containing 50 mM Tris-HCl (pH 7.5), 1% (v/v) Triton X-100,
150 mM NaCl, 2 mM PMSF, 1.7 mg/ml Aprotinin, 50 mM
NaF, and 1 mM sodium orthovanadate. The protein concentra-
tion was measured using the Bradford assay (Bio-Rad Laborato-
ries, Milan, Italy). Proteins derived from bladder and placenta
(1000 mg) were immunoprecipitated by using 2 mg of a polyclonal
sheep anti-E5 antibody (a kind gift by Dr. M.S. Campo) and 30 ml
of Protein A/G-Plus Agarose (Santa Cruz Biotechnology, CA,
USA). Immunoprecipitates were washed four times in complete
lysis buffer (above), finally heated in 1X Laemmli sample buffer at
100uC for 10 min. Immunoprecipitates were separated on
polyacrylamide gels and transferred to nitrocellulose filter
membranes (Ge Healthcare Life Sciences, Chalfont St Giles,
UK) for 16 h at 30 mA in 192 mM glycine/25 mM Tris-HCl
(pH 7.5)/10% methanol. Membranes were blocked for 1 h at
room temperature in 5% non-fat dry milk, incubated with anti-E5,
anti-PDGFbR and anti-Tyr
770 phosphorylated PDGFbR antibod-
ies (Santa Cruz Biotechnology, CA, USA) overnight at 4uC. After
three washes in Tris-buffered saline, membranes were incubated
with rabbit anti-sheep IgG-horseradish peroxidase (HRP) (Santa
Cruz Biotechnology, CA, USA) or with goat anti-rabbit IgG-HRP
(Bio-Rad Laboratories, Milan, Italy) for 60 min at room
temperature. Proteins were visualized by enhanced chemilumi-
nescence system (Western Blotting Luminol Reagent, Santa Cruz
Biotechnology, CA, USA).
Immunohistochemistry
Placental sections from both cows affected with urinary bladder
tumors and from apparently healthy cows were processed with the
same procedures. Briefly, the sections were deparaffinized and
then endogenous peroxidase activity was blocked by incubation in
0.3% H2O2 in methanol for 20 min. Antigen retrieval was
performed by pretreating with microwave heating (twice for 5 min
each at 750 W) in citrate buffer pH 6.0. The slides were washed
three times with phosphate buffered saline (PBS), pH 7.4, 0.01 M,
then incubated for 1 h at room temperature with rabbit serum
(Sigma-Aldrich, Milan, Italy) diluted at 1 in 10 in PBS. The excess
serum was drained off and a polyclonal sheep anti-BPV-2 E5
Placental Papillomavirus Infection in Cows
PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e33569primary antibody (a kind gift by Dr. M.S. Campo) diluted at 1 in
40,000 in PBS, was applied for 1 h at room temperature in a
humid chamber. Following incubation, the sections were rinsed
three times for 5 min with PBS before application of the rabbit
anti-sheep biotinylated secondary antibody (Santa Cruz Biotech-
nology, Inc., CA, USA), diluted at 1 in 100 in PBS for 45 min at
room temperature. For E2 and L1 detection the slides were
washed three times with PBS, pH 7.4, 0.01 M, then incubated for
1 h at room temperature with protein block serum-free (DakoCy-
tomation, Denmark). Polyclonal rabbit anti-BPV-2 E2 primary
antibody (a kind gift by Dr. E. Androphy) diluted at 1 in 200/300
in PBS and a monoclonal mouse anti-HPV-16 L1 (late protein)
(Chemicon International, CA, USA) diluted at 1 in 200 in PBS
were applied overnight at 4uC in a humid chamber. The sections
were rinsed three times for 5 min with PBS, incubated for 40 min
at room temperature with appropriate biotinylated secondary
antibody (labelled streptavidin-biotin (LSAB) Kit; DakoCytoma-
tion, Denmark). Finally, all the sections were washed three times
with PBS and then incubated with streptavidin-conjugated to
horseradish peroxidase (LSAB Kit; DakoCytomation, Denmark).
Color development was obtained by treatment with diaminoben-
zidine (DakoCytomation, Denmark) for 5–20 min. Sections were
counter stained with Mayer’s hematoxylin.
Immunofluorescence
Two-color immunofluorescence staining was performed with all
placental samples to assess the presence of E5 and PDGFbR also
in uterine and chorionic epithelium. Briefly, the sections were
deparaffinized, rinsed in PBS and heated in a microwave oven in
citrate buffer (as above) to allow antigen unmasking. Slides were
then pre-incubated with normal donkey serum diluted at 1 in 20 in
PBS for 30 min, and overlaid with polyclonal sheep anti-E5
diluted at 1 in 50 in PBS for 2 h at room temperature in a humid
chamber. Then, a polyclonal goat anti-p-PDGFbR antibody
(Santa Cruz Biotechnology Inc., CA., U.S.A.) was applied
overnight diluted at 1 in 50 in PBS. A secondary antibody Alexa
Fluor 488 donkey anti-sheep (Invitrogen, Molecular Probes) and a
secondary antibody Alexa Fluor 546 donkey anti-goat (Invitrogen,
Molecular Probes), diluted at 1 in 100 in PBS, were applied for 2 h
at room temperature.
After washing 3 times with PBS, the slides were mounted under
aqueous medium (Sigma-Aldrich, Milan, Italy). For observation
and photography, a laser scanning confocal microscope LSM-510
(Zeiss, Go ¨ttingen, Germany) was used.
Western blot analysis for total and phosphorylated
PDGFbR, E2, L1
Placental samples were solubilized at 4uC in lysis buffer
containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton
X-100. Immediately prior to use, the following reagents were
added: 1 mM DTT, 2 mM PMSF, 1.7 mg/ml Aprotinin, 25 mM
NaF, 1 mM Na3VO4 (Sigma-Aldrich, Milan, Italy).
Figure 1. PCR amplification of DNA samples. Lane M, molecular mass marker (HyperLadder II Bioline); lanes 1–2 placental samples from healthy
animals without BPV-2 DNA; lanes 3–4 placental samples from two of four animals affected with urinary bladder tumors showing BPV-2 DNA; lane C+,
positive control; lane C2, negative control. The arrow indicates the position of the 125 bp BPV-2 PCR product.
doi:10.1371/journal.pone.0033569.g001
Figure 2. E5 immunoprecipitation. The presence of E5 protein
detected by immunoprecipitation. Lanes 1–2: placenta from healthy
cows. Lanes 3–4: placenta from two of four cows with papillomavirus-
associated tumors of the urinary bladder.
doi:10.1371/journal.pone.0033569.g002
Figure 3. E5 immunohistochemistry. The presence of E5 oncopro-
tein seen by immunohistochemistry in the cells of chorionic epithelium
(black arrows). Insert: corresponding negative control section.
doi:10.1371/journal.pone.0033569.g003
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concentration was measured using the Bradford assay (Bio-Rad
Laboratories, Milan, Italy). For Western blotting, 50 mg of lysate
proteins were heated at 100uC in 4X premixed Laemmli sample
buffer. Proteins were subjected to sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS–PAGE) (7.5% polyacryl-
amide) under reducing conditions.
After electrophoresis, proteins were transferred onto nitrocellu-
lose filter membranes (GE Healtcare Life Sciences, Chalfont St
Giles, UK) for 1 h at 350 mA in 192 mM glycine/25 mM Tris-
HCl (pH 7.5)/10% methanol. The membranes were blocked with
5% non-fat dry milk in Tris-buffered saline (TBS, pH 7.5) for 1 h
Figure 5. PDGFb-R overexpression and p-PDGFb-R activation. (A) Total protein extracts from placental tissue lysates were generated and used
in Western blot analysis with an antibody specific for total PDGFb-R and a phosphospecific PDGFb-R antibody that recognized p-PDGFb-R
phosphorylated at Tyr770. Lanes 1–2: healthy animals. Lanes 3–4: placental tissue from two of the four cows with papillomavirus-associated tumors of
the urinary bladder. Actin protein levels were detected to ensure equal protein loading. (B) Quantitative densitometric analysis of the gels was
performed with Image Lab software (ChemiDoc; Bio-Rad Laboratories) and significance determined by the Student T-test (P#0.01).
doi:10.1371/journal.pone.0033569.g005
Figure 4. E5-PDGFß-R co-precipitation. The presence of total and
phosphorylated PDGFß-R was detected in E5 immunoprecipitates.
Lanes 1–2: placenta from healthy cows. Lanes 3–4: placenta from two of
four cows with papillomavirus-associated tumors of the urinary bladder.
doi:10.1371/journal.pone.0033569.g004
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membranes were probed with Tyr
770-phosphorylated anti-
PDGFbR and non-phosphorylated anti-PDGFbR antibodies
(Santa Cruz Biotechnology, CA, USA), an anti-E2 antibody and
anti-L1 antibody (clone BPV1-1H8, AbCam, Cambridge, UK) for
an overnight incubation at 4uC. After three washes in Tris-
buffered saline, membranes were incubated with horseradish
peroxidase-conjugated anti-rabbit IgG (Santa Cruz Biotechnology,
CA, USA) or anti-mouse IgG (Bio-Rad Laboratories, Milan, Italy)
respectively, for 1 h at room temperature. After appropriate
washing steps, bound antibody was visualized by an enhanced
chemiluminescence system (Western Blotting Luminol Reagent,
Santa Cruz Biotechnology, CA, USA).
Transmission Electron Microscopy
Formalin-fixed placenta was cut into small pieces. They were
washed in 0.1 M phosphate buffer (pH 7.4) for 20 min 5 times
and post fixed in 1% OsO4 in phosphate buffer (pH 7.4) for 1 h.
They were washed in 0.1 M phosphate buffer (pH 7.4), and then
dehydrated through graded alcohols, and embedded in Epon 812
epoxy resin (Polyscience, Niles, IL, USA). The whole process of
inclusion was performed using the Leica EM TP automated
routine tissue processor station (Leica Microsystems). Ultra thin
sections (60–70 nm) were cut on an EM UC6 ultramicrotome
(Leica Microsystems) and collected onto 300-mesh Formvar-
coated grids. Sections were counterstained with uranyl acetate and
lead citrate and examined with a JEOL JEM-1011 transmission
electron microscope (JEOL, Tokyo, Japan) equipped with a
thermionic tungsten filament and operated at an acceleration
voltage of 100 kV. Images were taken using a Morada cooled
slow-scan CCD camera (3783X2672 pixels) and micrographs were
taken with iTEM software (Olympus Soft Imaging System GmbH,
Munster, Germany). The same procedure was used to obtain ultra
thin sections from placenta of unaffected, healthy cows.
Results
Histological examination of the bladder tumors detected
microscopic patterns consistent with low grade papillary carcino-
mas (three cases) and with high grade papillary carcinoma (one
case) and all of them were positive for E5 oncoprotein as reported
elsewhere [2].
DNA of PCR-quality was recovered from all the placental
samples. PCR analysis demonstrated the presence of BPV-2 DNA
only in the samples from cows affected with urothelial bladder
tumors in which a fragment of the expected size (125 bp) was
Figure 6. E5-pPDGFb-R co-localization. E5-pPDGFb-R co-localiza-
tion shown in chorionic epithelium by laser scanning confocal
microscopy. (A) E5 expression in red. (B) pPDGFb-R activation in green.
(C) Co-localization of the proteins in yellow. (D) Epithelium of
unaffected placenta from a healthy cow showing no immunofluores-
cence for E5.
doi:10.1371/journal.pone.0033569.g006
Figure 7. L1 detection. The presence of L1 protein detected in the
placenta by Western blot. Lanes 1–2: placenta from healthy cows. Lanes
3–4: placenta from two of the four cows with papillomavirus-associated
tumors of the urinary bladder.
doi:10.1371/journal.pone.0033569.g007
Figure 8. L1 immunohistochemistry. Immunohistochemical analy-
sis confirmed the presence of L1 protein, the major viral structural
protein, in the uterine and chorionic epithelium. Insert: corresponding
negative control section.
doi:10.1371/journal.pone.0033569.g008
Figure 9. E2 detection. The presence of E2 protein detected in the
placenta by Western blot. Lanes 1–2: placenta from healthy cows. Lanes
3–4: placenta from two of the four cows with papillomavirus-associated
tumors of the urinary bladder.
doi:10.1371/journal.pone.0033569.g009
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oncoprotein was also detected by immunoprecipitation (Figure 2)
and both in the uterine endometrial and chorionic epithelium by
immunohistochemistry. E5 was found to be located mostly in the
cytoplasm; however, it was also seen associated to the membrane
(Figure 3).
Western blot analysis from E5 immunoprecipitates revealed the
presence of total and phosphorylated (activated) PDGFbR,
indicating the two proteins were in a physical complex (Figure 4).
The receptor protein appeared to be overexpressed and its
phosphorylation was increased in the placental samples from cows
suffering from urinary bladder tumors compared to the healthy
ones as detected in total lysates (Figure 5). Morphologically,
PDGFbR expression appeared to occur in the epithelium lining
villi and criptae of placentomes and in the epithelial cells of
interplacentomal regions. The activated PDGFbR was complexed
and co-localized both at membrane and cytoplamatic levels with
the E5 oncoprotein as documented by laser scanning confocal
microscope (Figure 6).
As it is still controversial whether productive infections can take
place naturally in the placenta, we investigated the expression of
the major capsid protein, L1, believed to be only expressed in
productive infections of papillomavirus [5,17]. Western blot
analysis revealed L1 expression in total protein extracts from
placental samples of cows affected with urinary bladder tumors
only (Figure 7). Immunohistochemical investigations confirmed
the presence of L1 protein in the cytoplasm and nuclei of cells of
the uterine endometrial and chorionic epithelium. Trophoblastic
cells appeared to be the major target for L1 protein expression
(Figure 8).
As it has been suggested that the early protein E2, involved in a
number of processes that are essential for the viral life-cycle, is
among the first proteins to be expressed during a productive
infection [16], we studied the expression of this protein. E2 was
detected by Western blot and its expression was confirmed
immunohistochemically. It was seen both in the cytoplasm and,
mostly, in nuclei of epithelial cells of placentome and of
interplacentomal regions of cows affected with urinary bladder
tumors only (Figures 9 and 10). Ultrastructurally, electron dense
particles, 45–50 nm in diameter and identified as viral particles,
were seen in uterine and chorionic epithelium. They were
manifested as chromatin-associated clusters or randomly scattered
in the nuclei (Figures 11 and 12). No electron dense particles were
seen in nuclei from placenta of unaffected, healthy cows
(Figure 13).
Figure 10. E2 immunohistochemistry. Immunohistochemical
detection of E2 protein in the uterine and chorionic epithelium. Notice
the nuclear immunoreactivity. Insert: corresponding negative control
section.
doi:10.1371/journal.pone.0033569.g010
Figure 11. Presence of viral particles. Electron microscopical
examination of a nucleus of trophoblastic cell showing randomly
scattered electron dense viral particles (white and yellow arrows).
615,000. Insert: higher magnification of viral particles shown by yellow
arrow. 650,000.
doi:10.1371/journal.pone.0033569.g011
Figure 12. Presence of viral particles. Electron microscopical
examination showed numerous clusters of chromatin-associated
electron dense particles, 45–50 nm in diameter identified as viral
particles (yellow and white arrows) in the nucleus of a trophoblastic cell.
615,000. Insert: higher magnification of viral particles shown by yellow
arrow. 650,000.
doi:10.1371/journal.pone.0033569.g012
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Our study provides evidence for a productive BPV-2 infection
in the placenta of cows suffering from naturally acquired, BPV-2-
induced bladder tumors. Microscopic and submicroscopic inves-
tigations show that, in analogy to HPV infection in man [18],
bovine placental trophoblasts are also the target for BPV
infections. Unfortunately, ultrastructural studies were performed
on formalin-fixed tissues, which have not allowed us to follow
routine procedures to obtain an accurate preservation of cell
structures. It is worthwhile noting that various HPV types are able
to complete their life-cycle in cultured trophoblasts [14,15,19]. In
addition, HPV DNA has been found in placental trophoblastic
cells from women with cervical and/or oral HPV infection history
[13] and in trophoblasts of pathological placentas from women
with spontaneous abortion [18]. Recently, HPV L1 DNA has been
detected in the placenta of women suffering from reproductive
disorders and of a patient affected by epidermodysplasia
verruciformis (EV), a skin disease characterized by an abnormal
genetic susceptibility to a group of HPVs [15,20]. Furthermore,
HPV-16 and HPV-62 E6/E7 DNA was detected in the
transabdominally obtained placental cells from apparently healthy,
pregnant women [11]. DNA sequences of BPV-1, BPV-2 and
BPV-4 were also detected in the placenta and amniotic fluid of
pregnant cows although clinical implications of these results
remain to be elucidated [21]. It has been suggested that gene
expression of HPVs in trophoblastic cells is regulated by
pregnancy hormones such as endogenous progesterone [22].
Current findings support the view that PVs are not strictly
keratinocyte-specific. We have recently shown that blood cells,
particularly CD4+ and CD8+ lymphocytes of hematuric cattle, are
additional sites of a productive BPV-2 infection [10]. It has also
been shown that experimental infection of foals by BPV-1
comprises a viraemic phase [23]. Therefore, we believe that
placental BPV-2 infection may preferably take place via
bloodstream although alternative routes also exist. A similar
pathway has been hypothesized to occur in man [24,25].
However, the viraemic phase has not been confirmed for HPV
and hematogenous transmission of HPV remains a controversial
issue [26]. Bodaghi et al. detected HPV-16 DNA in the blood of
sexually naı ¨ve children that had acquired HIV-1 infection via
blood transfusion [27]. Furthermore, our data emphasizes that
BPV-2 E5 oncoprotein binds to the activated PDGFßR in the
placental trophoblasts, which raises a number of important
questions that warrant further investigations.
Genetic and biochemical data indicate that the activation of the
PDGFbR is an important molecular pathway by which E5
oncoprotein becomes responsible for cell transformation in a
variety of cell systems [28]. E5 forms a stable complex with the
PDGFbR and induces dimerization of the receptor, activation of
the tyrosine kinase activity, autophosphorylation of the intracel-
lular domain of the receptor on tyrosine, mitogenic signaling and
cell transformation [29]. However, it has also been shown that E5,
when retained in the Golgi, still induces PDGF receptor
autophosphorylation but does not transform cells [30].
What is the biological significance of the E5-pPDGFbR
complex in the placenta? Tumors of the placental epithelium
have not been clearly substantiated in domestic animals [31].
Congenital tumors associated with papillomavirus infection are
extremely rare in cattle [32,33,34], suggesting that E5 in the
placenta could rarely be responsible for cell transformation. It is
conceivable that the pregnancy period might not be enough for
cell transformation by E5/PDGFbR complex. It has been
suggested that successful signaling through PDGFbR requires
Figure 13. Placentomal epithelium. Nucleus of a trophoblastic cell from an uninfected placenta of a healthy cow without any electron dense
particles. 615,000.
doi:10.1371/journal.pone.0033569.g013
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induce downstream signaling [30]. Accordingly, the activation of
the PDGFbR has been shown to play an important role in in vivo
bladder carcinogenesis only in adult cattle as tumors of the urinary
bladder are known to occur in 4–8-year-old cattle [2,35].
Alternatively, the activation of the PDGFbR by E5 oncoprotein
during in utero infections could play an important role also in non-
carcinogenetic events.
Trophoblasts share many properties with malignant cancer cells
and are rich in receptors for many growth factors including the
PDGF receptor [36]. PDGFbR signaling is required for the
maturation of the trophoblasts and fetal placental vasculature as
well [37,38], thus playing a crucial role in mammalian
development [37]. The PDGFbR expression is dynamic being
low in vivo during development but increasing dramatically during
inflammation [39]. It is well-known that PDGFbR is expressed in
mesenchyme, particularly in vascular smooth muscle cells (SMCs)
and pericytes. It is involved in the angiogenesis and organogenesis
of developing kidneys and lungs [37]. More recently, PDGFbR
signaling has been shown to be important also in cardiac
development [40].
In our study, the upregulation of PDGFbR prompts the
intriguing hypothesis that PDGFbR signaling can be involved in
an abnormal organogenesis that might lead to a compromised
gestation. We found this complex also in fetal organs (Roperto et
al., manuscript in preparation). Therefore, placental infections
with BPVs may ultimately be associated with placental defects and
abnormal fetal development resulting in reproductive disorders. It
has been suggested that HPV infection can be responsible for a
severe placental dysfunction resulting in preterm delivery and
spontaneous abortion [15,22,41]. Prenatal transmission is a known
mode of vertical papillomavirus transmission and an actual
mechanism of virus infection of the fetus via transplacental
transmission appears to take place both in humans
[13,20,26,42,43,44] and in cows [21,45].
According to Castellsague ´ et al. [46], future studies are needed
to establish sensitive detection methods for reliable distinction
between latent and active/productive HPV. This may e.g. be
achieved by the use of qPCR-based assays with probes designed to
specifically recognize viral mRNA splicing products.
To date, BPV infection has not been thought important in
placental abnormalities in cows. Our findings provide a scientific
basis for further investigations about the role of BPV in pregnant
cows in compromising placental function that may result in
adverse pregnancy outcomes. It is worthwhile noting that the
incidence of reproductive disorders, like infertility and abortions,
caused by infectious agents is continuously increasing thus leading
to substantial economic losses [47]. This is even more so as the
major causes of miscarriage are only rarely identified [8].
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